Bronchodilators
Links shared publicly online about this topic
Bronchodilators - What Are Bronchodilators Video - About.com
video.about.com — “When bronchi are constricted mucus levels increase. Bronchodilators are medications that treat constricted bronchi.” View full resource at video.about.com
Most Recently Shared on May 14, 2010 at 3:26 am By:
Pat Physician, Doctor, Pediatrician, and Internist
What Are Bronchodilators? Check Out This Video That Shows How Your Rescue Inhaler Works http://cli.gs/MgMXXV
Maternal bronchodilator use and the risk of orofacial clefts
humrep.oxfordjournals.org — “Maternal bronchodilator use and the risk of orofacial clefts” View full resource at humrep.oxfordjournals.org
Most Recently Shared on September 22, 2011 at 12:05 pm By:
Juan C. Ivancevich, MD Doctor, Internist, Allergist, and Physician
Association between maternal bronchodilator use during the periconceptional period and the risk of cleft lip http://t.co/dW2gYpHp
Pediatrics Medical News about bronchodilator response
mdlinx.com — “An elevated bronchodilator response predicts large airway inflammation in mild asthma” View full resource at mdlinx.com
Most Recently Shared on January 22, 2010 at 10:29 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Peds: An elevated bronchodilator response predicts large airway inflammation in mild asthma: Pediatric Pulmonology http://url4.eu/1BwGN
Bronchodilation in asthmatics maintained with daily dosing of RPL554 - Drugs.com MedNews
drugs.com — “Highlights Identical bronchodilator responses seen after 1, 3 and 6 days of treatment No evidence of RPL554 accumulation in plasma over 6 days There were no saf” View full resource at drugs.com
Most Recently Shared on August 23, 2011 at 7:14 pm By:
Drugs and Devices OW OW Health
Bronchodilation in asthmatics maintained with daily dosing of RPL554: Highlights • Identical bronchodilato... http://t.co/9zbiDF1 #drug
Leading Patient Education Organization To Asthma Patients: Talk To Your Healthcare Provider About FDA 12-Hour Bronchodilator Warnings
medicalnewstoday.com — “Allergy & Asthma Network Mothers of Asthmatics (AANMA) encourages patients to make informed decisions about recent U.S. Food and Drug Administration (FDA) recommendations affecting patients using” View full resource at medicalnewstoday.com
Most Recently Shared on March 3, 2010 at 5:08 pm By:
Leading Patient Education Organization To Asthma Patients: Talk To Your Healthcare Provider About FDA 12-Hour Bronchod... http://mnt.to/3ypd
Emergency Medicine Article | Effects of Nebulized Bronchodilator Therapy on Heart Rate and Arrhythmias in Critically Ill Adult Patients
mdlinx.com — “Effects of Nebulized Bronchodilator Therapy on Heart Rate and Arrhythmias in Critically Ill Adult Patients” View full resource at mdlinx.com
Most Recently Shared on October 6, 2011 at 10:22 pm By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Effects of Nebulized Bronchodilator Therapy on Heart Rate and Arrhythmias in Critically Ill Adult Patients: Chest http://t.co/HPRywJQf #ER
LABA Bronchodilator for Asthma - Long Acting Beta Agonist Provide Asthma Symptom Control
asthma.about.com — “LABA bronchodilators can be an important part of your asthma care plan, but there are some safety concerns you need to be aware of. Learn what you need to know about LABAs.” View full resource at asthma.about.com
Most Recently Shared on September 13, 2010 at 6:54 pm By:
Pat Physician, Doctor, Pediatrician, and Internist
LABA Bronchodilator for Asthma - Long Acting Beta Agonist Provide Asthma Symptom Control - http://bit.ly/a41GG3
Nursing Medical News about Administration, Inhalation Bronchodilator Agents Pulmonary Disease, Chronic Obstructive Adrenal Cortex Hormones
mdlinx.com — “Mono- and Combination Therapy of Long-Acting Bronchodilators and Inhaled Corticosteroids in Advanced COPD” View full resource at mdlinx.com
Most Recently Shared on May 30, 2010 at 7:08 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Mono- and Combination Therapy of Long-Acting Bronchodilators and Inhaled Corticosteroids in Advanced COPD:... http://bit.ly/ad1ajQ #Nursing
FDA advisory committee recommends US approval of Novartis once-daily bronchodilator QAB149 for COPD
novartis.com — “FDA advisory committee recommends US approval of Novartis once-daily bronchodilator QAB149 for COPD” View full resource at novartis.com
Most Recently Shared on March 9, 2011 at 2:40 pm By:
eyeonfda Health Lawyer and Pharma
FDA advisory committee recommends US approval of Novartis once-daily bronchodilator QAB149 for COPD - http://ow.ly/4aQ4K
FDA Approves Once-Daily Bronchodilator for COPD - QualityPoint Technologies
qualitypointtech.net — “As a once-a-day drug, the new long-acting beta2-adrenergic agonist promises greater patient adherence than twice-daily LABAs. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on July 2, 2011 at 12:45 am By:
FDA Approves Once-Daily Bronchodilator for COPD: As a once-a-day drug, the new long-acting beta2-adrenergic agonis... http://bit.ly/kUOvxK
LABA Bronchodilator for Asthma - Long Acting Beta Agonist Provide Asthma Symptom Control
asthma.about.com — “LABA bronchodilators can be an important part of your asthma care plan, but there are some safety concerns you need to be aware of. Learn what you need to know about LABAs.” View full resource at asthma.about.com
Most Recently Shared on October 10, 2011 at 8:37 pm By:
Pat Physician, Doctor, Pediatrician, and Internist
What You Need To Know About Your LABA-- Risks, Benefits & Side Effects http://t.co/PRfAMRml
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
novartis.com — “Basel, December 3, 2009 - Novartis announced today that the European Commission (EC) has approved Onbrez Breezhaler (QAB149 or indacaterol) in both 150 mcg and 300 mcg doses as a new once-daily maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (COPD).” View full resource at novartis.com
Most Recently Shared on December 3, 2009 at 1:40 pm By:
eyeonfda Health Lawyer and Pharma
Novartis gets EU approval for new COPD treatment - http://ow.ly/Ias3
PharmaLive: Novartis Receives FDA Approval for Arcapta Neohaler, A Novel Once-Daily Bronchodilator for Chronic Obstructive Pulmonary Disease
pharmalive.com — “PharmaLive: Novartis Receives FDA Approval for Arcapta Neohaler, A Novel Once-Daily Bronchodilator for Chronic Obstructive Pulmonary Disease” View full resource at pharmalive.com
Most Recently Shared on July 5, 2011 at 6:20 pm By:
PharmaLive Pharma and Health News
Daily Advantage - FDA OKs Novartis COPD Bronchodilator - http://tinyurl.com/3olyl92
Phase III data show Novartis investigational bronchodilator QAB149 significantly improves lung function over current treatments in COPD[1],[2]
novartis.com — “Basel, May 21, 2009 - Initial results from three pivotal phase III trials show the Novartis investigational bronchodilator QAB149 (indacaterol) could deliver clinically relevant* lung function improvements, within five minutes of the first dose, lasting for 24 hours in patients with chronic obstructive pulmonary disease (COPD)[3],[4],[5].” View full resource at novartis.com
Most Recently Shared on May 21, 2009 at 5:37 am By:
Phase III data show Novartis investigational bronchodilator QAB149 significantly improves lung function over cur.. http://twurl.nl/456hie
FDA informs Novartis of extension to US regulatory review period for QAB149, a novel once-daily bronchodilator for treatment of COPD
novartis.com — “FDA informs Novartis of extension to US regulatory review period for QAB149, a novel once-daily bronchodilator for treatment of COPD” View full resource at novartis.com
Most Recently Shared on March 23, 2011 at 3:24 pm By:
eyeonfda Health Lawyer and Pharma
#FDA extends regulatory review period for Novartis #COPD drug http://ow.ly/4kMob
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Pat
I am the about.com guide to asthma. Asthma news and information.
-
Juan C. Ivancevich, MD
Allergist - Head Allergy & Immunology, Santa Isabel Clinic, Buenos Aires. Assistant Professor of Immunology, Medicine School, Universidad del Salvador, Buenos Aires. Member of the Board of Directors, World Allergy Organization. President of the South Cone Chapter on the Latin American Society of Allergy, Asthma & Immunology.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
